- Investing Ideas
- Danish Biotech Stocks
Danish Biotech Stocks
Results
7
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
7 companies
Novo Nordisk
Market Cap: DKK 1.4t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 310.60
7D
5.1%
1Y
-44.3%
Genmab
Market Cap: DKK 117.3b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,904.50
7D
-2.7%
1Y
26.6%
H. Lundbeck
Market Cap: DKK 38.0b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 39.04
7D
4.2%
1Y
-6.9%
Zealand Pharma
Market Cap: DKK 28.2b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 399.70
7D
-1.9%
1Y
-46.9%
Bavarian Nordic
Market Cap: DKK 14.9b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 192.00
7D
-0.7%
1Y
12.2%
Gubra
Market Cap: DKK 6.4b
A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.
GUBRA
DKK 390.60
7D
-5.0%
1Y
-41.2%
Strategic Partners
Market Cap: DKK 23.4m
Does not have significant operations.
STRAP
DKK 562.00
7D
-1.7%
1Y
-33.1%